Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective on the Current Algorithm and Future Directions

SIMPLE SUMMARY: The treatment landscape of metastatic renal cell carcinoma has changed dramatically over the course of the last decade. The use of doublet immunotherapy or targeted therapy/immunotherapy regimens has become the standard of care. Herein, we outline the important elements and considera...

Descripción completa

Detalles Bibliográficos
Autores principales: Govindarajan, Ameish, Castro, Daniela V., Zengin, Zeynep B., Salgia, Sabrina K., Patel, Jalen, Pal, Sumanta K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106028/
https://www.ncbi.nlm.nih.gov/pubmed/35565179
http://dx.doi.org/10.3390/cancers14092049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106028/
https://www.ncbi.nlm.nih.gov/pubmed/35565179
http://dx.doi.org/10.3390/cancers14092049

Ejemplares similares